BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21239513)

  • 1. Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism.
    Marfella R; Ferraraccio F; Rizzo MR; Portoghese M; Barbieri M; Basilio C; Nersita R; Siniscalchi LI; Sasso FC; Ambrosino I; Siniscalchi M; Maresca L; Sardu C; Amato G; Paolisso G; Carella C
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1015-20. PubMed ID: 21239513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome activity as a target of hormone replacement therapy-dependent plaque stabilization in postmenopausal women.
    Marfella R; Di Filippo C; Portoghese M; Ferraraccio F; Crescenzi B; Siniscalchi M; Barbieri M; Bologna C; Rizzo MR; Rossi F; D'Amico M; Paolisso G
    Hypertension; 2008 Apr; 51(4):1135-41. PubMed ID: 18259030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morning blood pressure surge as a destabilizing factor of atherosclerotic plaque: role of ubiquitin-proteasome activity.
    Marfella R; Siniscalchi M; Portoghese M; Di Filippo C; Ferraraccio F; Schiattarella C; Crescenzi B; Sangiuolo P; Ferraro G; Siciliano S; Cinone F; Mazzarella G; Martis S; Verza M; Coppola L; Rossi F; D'Amico M; Paolisso G
    Hypertension; 2007 Apr; 49(4):784-91. PubMed ID: 17309948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased activity of the ubiquitin-proteasome system in patients with symptomatic carotid disease is associated with enhanced inflammation and may destabilize the atherosclerotic plaque: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Di Filippo C; Baldi A; Siniscalchi M; Sasso FC; Portoghese M; Carbonara O; Crescenzi B; Sangiuolo P; Nicoletti GF; Rossiello R; Ferraraccio F; Cacciapuoti F; Verza M; Coppola L; Rossi F; Paolisso G
    J Am Coll Cardiol; 2006 Jun; 47(12):2444-55. PubMed ID: 16781372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment.
    Marfella R; D'Amico M; Esposito K; Baldi A; Di Filippo C; Siniscalchi M; Sasso FC; Portoghese M; Cirillo F; Cacciapuoti F; Carbonara O; Crescenzi B; Baldi F; Ceriello A; Nicoletti GF; D'Andrea F; Verza M; Coppola L; Rossi F; Giugliano D
    Diabetes; 2006 Mar; 55(3):622-32. PubMed ID: 16505224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-associated differences in plaque phenotype of patients undergoing carotid endarterectomy.
    Hellings WE; Pasterkamp G; Verhoeven BA; De Kleijn DP; De Vries JP; Seldenrijk KA; van den Broek T; Moll FL
    J Vasc Surg; 2007 Feb; 45(2):289-96; discussion 296-7. PubMed ID: 17264005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaque-infiltrating T lymphocytes in patients with carotid atherosclerosis: an insight into the cellular mechanisms associated to plaque destabilization.
    Profumo E; Buttari B; Tosti ME; Tagliani A; Capoano R; D'Amati G; Businaro R; Salvati B; Riganò R
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):349-57. PubMed ID: 22669090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
    Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
    Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of instability in high-risk carotid plaques are reduced by statins.
    Kunte H; Amberger N; Busch MA; Rückert RI; Meiners S; Harms L
    J Vasc Surg; 2008 Mar; 47(3):513-22. PubMed ID: 18295103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes.
    Cuccurullo C; Iezzi A; Fazia ML; De Cesare D; Di Francesco A; Muraro R; Bei R; Ucchino S; Spigonardo F; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A; Cipollone F
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2716-23. PubMed ID: 17038636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized LDL in human carotid plaques is related to symptomatic carotid disease and lesion instability.
    Sigala F; Kotsinas A; Savari P; Filis K; Markantonis S; Iliodromitis EK; Gorgoulis VG; Andreadou I
    J Vasc Surg; 2010 Sep; 52(3):704-13. PubMed ID: 20573470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis.
    Alvarez B; Ruiz C; Chacón P; Alvarez-Sabin J; Matas M
    J Vasc Surg; 2004 Sep; 40(3):469-75. PubMed ID: 15337875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between 5-lipoxygenase expression and plaque instability in humans.
    Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment.
    Balestrieri ML; Rizzo MR; Barbieri M; Paolisso P; D'Onofrio N; Giovane A; Siniscalchi M; Minicucci F; Sardu C; D'Andrea D; Mauro C; Ferraraccio F; Servillo L; Chirico F; Caiazzo P; Paolisso G; Marfella R
    Diabetes; 2015 Apr; 64(4):1395-406. PubMed ID: 25325735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.
    Grufman H; Schiopu A; Edsfeldt A; Björkbacka H; Nitulescu M; Nilsson M; Persson A; Nilsson J; Gonçalves I
    Atherosclerosis; 2014 Nov; 237(1):177-82. PubMed ID: 25240113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis.
    van Oostrom O; Velema E; Schoneveld AH; de Vries JP; de Bruin P; Seldenrijk CA; de Kleijn DP; Busser E; Moll FL; Verheijen JH; Virmani R; Pasterkamp G
    Cardiovasc Pathol; 2005; 14(3):126-34. PubMed ID: 15914297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 18 months of L-T4 replacement in women with subclinical hypothyroidism.
    Adrees M; Gibney J; El-Saeity N; Boran G
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):298-303. PubMed ID: 19094068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial progenitor cells in subclinical hypothyroidism: the effect of thyroid hormone replacement therapy.
    Shakoor SK; Aldibbiat A; Ingoe LE; Campbell SC; Sibal L; Shaw J; Home PD; Razvi S; Weaver JU
    J Clin Endocrinol Metab; 2010 Jan; 95(1):319-22. PubMed ID: 19897678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in carotid plaque content of macrophages, T cells and MMP-9 between patients with embolic and hemodynamic cerebral ischemia due to symptomatic carotid stenosis.
    Kunte H; Kunte G; Busch MA; Weichert W; Rückert RI; Harms L
    Atherosclerosis; 2010 Aug; 211(2):456-60. PubMed ID: 20427044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss.
    Bernardi LA; Cohen RN; Stephenson MD
    Fertil Steril; 2013 Nov; 100(5):1326-31. PubMed ID: 23954357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.